Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Millares, L. Setó, J. Sanz, M. Llatjos, F. Andreo, E. Castellà, E. Monsó (Badalona, Sabadell, Spain). Aberrant methylation in lung cancer identified by EBUS-TBNA as a marker of advanced staging. Eur Respir J 2012; 40: Suppl. 56, 4400

Member's Comments

No comment yet.

Related content which might interest you: EBUS-TBNA in lung cancer staging Source: Annual Congress 2008 - Ways into the mediastinum Year: 2008 Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Contribution of tumor markers to pretreatment staging of operable lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003 Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Implementation of EUS-FNA for lung cancer staging Source: Eur Respir J 2007; 30: Suppl. 51, 109s Year: 2007 Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond Year: 2013 Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 Improving lung cancer staging with EUS-FNA Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007 Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016 Success of EBUS TBNA in centrally located lung tumours after non-diagnostic bronchoscopy in patients with suspected lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 EUS-FNA as the first diagnostic procedure in lung cancer staging Source: Annual Congress 2009 - The ultrasound view Year: 2009 Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019 Staging with FDG-PET/CT influences stage-specific survival in non small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Imaging in oncology and infectious diseases Year: 2011 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 The role of endobronchial ultrasound in staging of lung cancer Source: Annual Congress 2004 - PG2 - Lung Cancer: bronchoscopic tools in diagnosis, staging, and treatment Year: 2004 Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer Source: Breathe, 14 (4) 342; 10.1183/20734735.027118 Year: 2018